Our findings on the TNF modulation of in utero hippocampal development in the context of maternal depression during pregnancy provide new inflammatory markers that can be potentially considered as one of the inflammation-targeted therapies for depression, particularly during pregnancy. This evidence concerns the gene TNF and major depressive disorder.